Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
AP-472 in Motor Disorders: NCT07432958 Clinical Landscape Report 2026
15 October 2026
NCT07432958 clinical landscape for Motor Disorders: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[18F]-FPyQCP in Pancreatic Ductal Adenocarcinoma: NCT07432633 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_13_1a4cebe3b5.jpg)
9 min read
[18F]-FPyQCP in Pancreatic Ductal Adenocarcinoma: NCT07432633 Clinical Landscape Report 2026
15 October 2026
NCT07432633 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Dexmedetomidine Hydrochloride in Alzheimer Disease: NCT07432997 Clinical Landscape Report 2026
15 October 2026
NCT07432997 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ifebemtinib in Pancreatic Ductal Adenocarcinoma: NCT07441174 Clinical Landscape Report 2026
15 October 2026
NCT07441174 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
HRS-4642 in KRAS G12D mutation pancreatic cancer: NCT07438106 Clinical Landscape Report 2026
15 October 2026
NCT07438106 clinical landscape for KRAS G12D mutation pancreatic cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Cadonilimab in Hepatocellular Carcinoma: NCT07446257 Clinical Landscape Report 2026
15 October 2026
NCT07446257 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BPI-572270 in Pancreatic Ductal Adenocarcinoma: NCT07435038 Clinical Landscape Report 2026
15 October 2026
NCT07435038 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Saruparib in Solid tumor: NCT07446855 Clinical Landscape Report 2026
15 October 2026
NCT07446855 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SK-NK in Ovarian Cancer: NCT07435701 Clinical Landscape Report 2026
15 October 2026
NCT07435701 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in CLDN18.2 positive Pancreatic Cancer: NCT07444541 Clinical Landscape Report 2026
15 October 2026
NCT07444541 clinical landscape for CLDN18.2 positive Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
YS-247 in Ovarian Epithelial Carcinoma: NCT07455071 Clinical Landscape Report 2026
15 October 2026
NCT07455071 clinical landscape for Ovarian Epithelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rimegepant Sulfate in Metastatic Pancreatic Ductal Adenocarcinoma: NCT07475234 Clinical Landscape Report 2026
15 October 2026
NCT07475234 clinical landscape for Metastatic Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…